Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies
- 6 February 2002
- journal article
- review article
- Published by Elsevier
- Vol. 69 (1) , 12-18
- https://doi.org/10.1016/s1297-319x(01)00335-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- Elevated interleukin-10 levels in patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.The Journal of Experimental Medicine, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987
- RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATIONThe Lancet, 1981
- The structure of eight distinct cloned human leukocyte interferon cDNAsNature, 1981